IMCR SCHEDULE 13G: SEC filing

Point72 Asset Management, L.P. and affiliated reporting persons

Filed with the SEC on · accession 0000919574-26-007502

IMCR filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 9, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.4% by the first close after the filing.

Summary of the filing

Point72 Asset Management, L.P. and affiliated reporting persons filed a Schedule 13G disclosing beneficial ownership of 2,720,043 ordinary shares (represented by ADSs) of Immunocore Holdings plc, equal to 5.2% of the class, as of November 6, 2026.

Key details

Ordinary shares beneficially owned (represented by ADSs)$2.7M
Ordinary shares represented by ADSs issuable upon conversion of convertible notes$502K
Reporting person / beneficial ownerPoint72 Asset Management, L.P.
Reporting person / general partner of point72 asset managementPoint72 Capital Advisors, Inc.
IssuerImmunocore Holdings plc
Controlling person of point72 asset management, l.p. and point72 capital advisors, inc.Steven A. Cohen
Authorized personJason M. Colombo

How IMCR stock reacted

Close before

$30.99

Nov 6, 2026

First close after

+2.39%

$31.73

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for IMCR, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IMCR?

Click here

Frequently asked questions

What did IMCR file with the SEC on Nov 9, 2026?

IMCR filed a SCHEDULE 13G (SEC filing). Point72 Asset Management, L.P. and affiliated reporting persons filed a Schedule 13G disclosing beneficial ownership of 2,720,043 ordinary shares (represented by ADSs) of Immunocore Holdings plc, equal to 5.2% of the class, as of November 6, 2026.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did IMCR stock react to this filing?

IMCR closed at $30.99 before the filing and $31.73 on Nov 9, 2026 (+2.39%).

Other IMCR SEC filings

Get alerts when IMCR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days